Zurich Cantonal Bank
GMAB icon

Zurich Cantonal Bank’s Genmab GMAB Stock Holding History

Zurich Cantonal Bank’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1
Closed -$30 – 2672
2024
Q1 		$30 Sell
1
-319
-100% -$9.37K ﹤0.01% 2695
2023
Q4 		$10.2K Sell
320
-41
-11% -$1.29K ﹤0.01% 2678
2023
Q3 		$12.7K Sell
361
-119
-25% -$4.54K ﹤0.01% 2728
2023
Q2 		$18.2K Sell
480
-110
-19% -$4.39K ﹤0.01% 2724
2023
Q1 		$22.3K Buy
+590
New +$22.7K ﹤0.01% 2733

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Zurich Cantonal Bank's GMAB Position: Q2 2024 in Review

Zurich Cantonal Bank sold out of Genmab (GMAB) in Q2 2024, closing a stake of 1 share — an estimated $30 sold.

Zurich Cantonal Bank first reported a position in GMAB in Q1 2023 and held it in 5 quarters. The position peaked at $22.3K in Q1 2023. 219 funds tracked by Wall St. Rank hold GMAB as of Q2 2024.

  • Zurich Cantonal Bank reported no remaining Genmab position as of Q2 2024 after selling out during the quarter.
  • Zurich Cantonal Bank sold 1 Genmab share in Q2 2024, an estimated $30.
  • Zurich Cantonal Bank first reported a position in Genmab in Q1 2023 and held it in 5 quarters.
  • Zurich Cantonal Bank's Genmab position peaked at $22.3K in Q1 2023.
  • 219 funds tracked by Wall St. Rank held Genmab as of Q2 2024.

Based on Zurich Cantonal Bank's 13F filing for Q2 2024, filed 29 Jul 2024.